about
Assessment of myocardial perfusion and viability by positron emission tomography.Postacquisition detection of tumor motion in the lung and upper abdomen using list-mode PET data: a feasibility study.Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteriesCardiovascular molecular imaging: an overview.PET/CT challenge for the non-invasive diagnosis of coronary artery disease.Hybrid image visualization tool for 3D integration of CT coronary anatomy and quantitative myocardial perfusion PET.Registration of myocardial PET and SPECT for viability assessment using mutual information.Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation.Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin.Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: evaluation in a porcine model of myocardial infarction.Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats.Global and regional functional measurements with gated FDG PET in comparison with left ventriculography.Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography.Effect of sympathetic reinnervation on cardiac performance after heart transplantation.Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis.Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer.Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography.Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart.Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus.Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus.Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients.Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model.Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism: a noninvasive study using positron emission tomography and magnetic resonance imaging.Local motion correction for lung tumours in PET/CT--first results.Myocardial blood flow and coronary flow reserve in children with "normal" epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography.The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction.A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy.Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.Sympathetic reinnervation, exercise performance and effects of beta-adrenergic blockade in cardiac transplant recipients.Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus--a randomized study using positron emission tomography.Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
P50
Q30585749-09477343-E0E6-4A06-BECF-0E0D9F4A843BQ31111389-A5A84A08-5322-4A39-8C5D-3DCE6CD395E4Q33418533-E2A01724-27E5-49F1-8C04-3DC2ABA5D2C0Q35581670-37D1C8F3-1DB7-40C3-9C52-5293571B15A7Q37530107-786061D6-4988-4411-87FE-3E8EF6D57B94Q37703592-5E566B4A-31BB-4A0F-B573-C80BA0498AEDQ38424042-77891E16-6E6A-4F87-8B76-30CB621C7C5CQ38781433-562D1DAB-EBEF-4041-A8E4-4B03403542B4Q39826304-8DE42D1B-F395-48F7-BE40-239B1CFE87D0Q40639602-248DDA6B-B0A9-4297-B980-0E0136CC48B0Q43037087-E3B64ADC-0E47-4327-97D7-A7C2BF1B2FE2Q43259548-9832E5C9-61DF-4B03-958A-D9685CE00229Q43266220-4C59825F-076F-49EE-B093-A06E8E9B156FQ43266221-3E5F24A0-F271-422C-A782-D3B2FDA9003CQ43266226-88071691-59AB-468D-B233-54EB65421948Q43576066-CC38824F-72F5-48AF-BAD6-1043A1F57D05Q43699894-5FE49965-C30F-46E1-91B1-0C913109942EQ43731019-6FDF6FDF-84AB-4992-92D6-22C862EFB8A3Q43803074-B9CAEC23-DADA-429A-A209-475E4234CE48Q43854296-39F4CD39-FACA-4274-A36E-E2E5AD8217EBQ43889073-F23BFD4E-1B7F-41A4-B71C-48D82263BB43Q43899365-682B32F2-CACD-41B7-82E2-74B2BE96579BQ43942295-048AF0A0-68B1-4EAD-A7D1-7853AAFA77C4Q44058905-055D16FA-0CAB-4EA9-A7C6-230D23070307Q44149780-040A00FF-5396-4318-8901-F93504F00F9FQ44233793-945D1114-18C0-423A-8828-27D7EC0DBB9FQ44444540-24182AC5-9311-46D3-B3A4-34DF6A526705Q44492163-74F19CCF-2CC3-485E-A1A2-A826898A34F9Q44509304-0A133AA7-3905-40E9-B23B-BCD0FA943F17Q44634384-A2EFE141-832D-4DE1-970B-C862866B2E7CQ44688636-D14EE92D-D038-473D-ADC8-5DDD618A11D2Q44803680-BB65435A-1AD7-4FB4-92EB-62C434D896A7Q44877964-D113D9F7-E593-4770-A589-D6494963440BQ44950894-0F1638FB-3C9A-425F-B4F6-1AEC1839DE96Q45004505-C6C9E914-7997-49F0-81FC-A1B0B2FAC092Q45038526-997FDC77-DD84-40AA-9038-EFF16FB70050Q45078683-0809747E-2C79-4B30-9819-5394563CA5EFQ45080579-4CE71253-7C18-4CAF-968D-317733B78FC8Q45231282-92B1F4A3-CE5D-4CC0-AD11-B8FD18295CEEQ46043745-E912F71E-9037-4952-BB54-30590C081386
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephan G Nekolla
@ast
Stephan G Nekolla
@en
Stephan G Nekolla
@es
Stephan G Nekolla
@nl
Stephan G Nekolla
@sl
type
label
Stephan G Nekolla
@ast
Stephan G Nekolla
@en
Stephan G Nekolla
@es
Stephan G Nekolla
@nl
Stephan G Nekolla
@sl
prefLabel
Stephan G Nekolla
@ast
Stephan G Nekolla
@en
Stephan G Nekolla
@es
Stephan G Nekolla
@nl
Stephan G Nekolla
@sl
P1053
L-1857-2013
P106
P21
P31
P3829
P496
0000-0002-8817-1482